News Detail
MUMBAI, 12 DEC 2019: In a breakthrough in research, IIT-Bombay scientists have developed technology to leverage a patient’s immune system to cure cancer. Such immunotherapy using CAR T-cells, a treatment for cancer, which costs Rs 3-4 crore in US, can be made available for ......
View Details
Source : The Times of India
Related News
- New target to beat cancer drug resistance (21-09-2023)
- New implantable device carries insulin-producing islet cells to control diabetes (20-09-2023)
- IIT Madras Researchers Developing A Portable, Turnkey Device To Detect Heavy Metals In Soil & Water (20-09-2023)
- Understanding Medicinal Drug Delivery Using Dry Powder Inhalers (DPIs) (20-09-2023)
- Molnupiravir: Concerns raised about possibility of creating new, treatment-resistant versions of the virus (19-09-2023)
- Various PFAS associated with breast, ovary, skin and uterus cancers in women (19-09-2023)
- IIT Jodhpur researchers develop antimicrobial peptide from snake venom (18-09-2023)
- Metformin, a common diabetes drug, can prevent muscle atrophy and fibrosis (17-09-2023)
- Layered Black Phosphorus Nanoflakes can kill antibiotic resistant superbugs (16-09-2023)
- Implantable bioartificial kidney aims to free patients from dialysis (14-09-2023)